Besides, patients with ACC had the higher alteration frequency (2.2%) of amplification than all the other tumours, and all mature B‐cell neoplasms cases with genetic alteration had deep deletion (2.08%) of YTHDC2 (Figure 2B). This evidence concerns the gene YTHDC2 and neoplasm.